| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 8.78e-08 | 46 | 248 | 8 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.03e-06 | 145 | 248 | 11 | GO:0004713 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PI4K2B SRC OBSCN MAP3K12 ITK PTK6 JAK1 PHKA1 PIK3C2B SPHK1 BTK POLN PLK1 FLT1 SGIP1 GNPTAB PAK5 NRG2 CRPPA YES1 CIT FRK ATM POLQ FYN MAP2K7 | 1.15e-04 | 938 | 248 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PI4K2B SRC OBSCN MAP3K12 ITK PTK6 JAK1 PHKA1 PIK3C2B SPHK1 BTK PLK1 FLT1 PAK5 NRG2 YES1 CIT FRK ATM FYN MAP2K7 | 2.21e-04 | 709 | 248 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | CD4 receptor binding | 2.90e-04 | 11 | 248 | 3 | GO:0042609 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | HEXA HGF ACADM SRC BCAT2 ALDH1L1 HMOX1 EPX PHKA1 QSOX1 GLB1 PIK3C2B GGTLC3 GLDC SPHK1 PARL TBC1D12 ABCC2 NOS2 GOT1 DNM2 WDR24 MPST EPM2A VPS39 KYAT1 LGALS8 UGT1A1 VPS13D TIMP4 SNX18 VPS41 LRP1 ATM RUFY4 | 1.96e-06 | 1253 | 244 | 35 | GO:0044248 |
| GeneOntologyCellularComponent | vacuole | HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 TBC1D12 PRMT1 WDR24 FUT10 VPS39 LARS1 CIT FRK CD1D AP5B1 VPS41 LRP1 LRP2 RUFY4 | 2.83e-05 | 913 | 245 | 26 | GO:0005773 |
| GeneOntologyCellularComponent | lysosome | HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 PRMT1 WDR24 FUT10 VPS39 LARS1 FRK CD1D AP5B1 VPS41 LRP1 LRP2 | 8.91e-05 | 811 | 245 | 23 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 PRMT1 WDR24 FUT10 VPS39 LARS1 FRK CD1D AP5B1 VPS41 LRP1 LRP2 | 8.91e-05 | 811 | 245 | 23 | GO:0000323 |
| GeneOntologyCellularComponent | lysosomal HOPS complex | 1.37e-04 | 2 | 245 | 2 | GO:1902501 | |
| GeneOntologyCellularComponent | vacuolar HOPS complex | 1.37e-04 | 2 | 245 | 2 | GO:1902500 | |
| GeneOntologyCellularComponent | endosome | MON2 PI4K2B HLA-DRB1 SRC PLD3 DYSF SPG21 EHD2 JAK1 SPHK1 TBC1D12 OSBPL6 DNM2 MRC1 FLT1 NEDD4L VPS39 ADAM30 ALS2 ECPAS CD1D AP5B1 SNX18 VPS41 LRP1 LRP2 ASTN1 FYN | 2.62e-04 | 1167 | 245 | 28 | GO:0005768 |
| GeneOntologyCellularComponent | spine apparatus membrane | 4.07e-04 | 3 | 245 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.98e-04 | 56 | 245 | 5 | GO:0099091 | |
| Domain | PROTEIN_KINASE_TYR | 5.19e-07 | 97 | 242 | 10 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.19e-07 | 97 | 242 | 10 | IPR008266 | |
| Domain | Tyr_kinase_cat_dom | 2.08e-06 | 88 | 242 | 9 | IPR020635 | |
| Domain | TyrKc | 2.08e-06 | 88 | 242 | 9 | SM00219 | |
| Domain | Pkinase_Tyr | 7.07e-06 | 129 | 242 | 10 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.28e-05 | 138 | 242 | 10 | IPR001245 | |
| Domain | SH2 | 1.32e-05 | 110 | 242 | 9 | SM00252 | |
| Domain | SH2 | 1.42e-05 | 111 | 242 | 9 | PS50001 | |
| Domain | SH2 | 1.53e-05 | 112 | 242 | 9 | IPR000980 | |
| Domain | - | 1.53e-05 | 112 | 242 | 9 | 3.30.505.10 | |
| Domain | SH3 | 2.62e-05 | 216 | 242 | 12 | PS50002 | |
| Domain | SH3 | 2.62e-05 | 216 | 242 | 12 | SM00326 | |
| Domain | SH3_domain | 3.14e-05 | 220 | 242 | 12 | IPR001452 | |
| Domain | SH2 | 5.07e-05 | 101 | 242 | 8 | PF00017 | |
| Domain | SH3_1 | 5.68e-05 | 164 | 242 | 10 | PF00018 | |
| Domain | Kinase-like_dom | SRC OBSCN MAP3K12 ITK PTK6 JAK1 PIK3C2B BTK PLK1 DNM2 FLT1 PAK5 YES1 CIT FRK ATM FYN MAP2K7 SOS1 | 8.81e-05 | 542 | 242 | 19 | IPR011009 |
| Domain | PH_dom-like | PSD MYO7A MYO10 OBSCN ITK JAK1 SBF1 BTK OSBPL6 DNM2 EPS8L2 ECT2L ALS2 CIT ELMO3 SOS1 | 1.47e-04 | 426 | 242 | 16 | IPR011993 |
| Domain | DNA_polymerase_A | 1.67e-04 | 2 | 242 | 2 | IPR002298 | |
| Domain | - | PSD MYO7A MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 EPS8L2 ECT2L ALS2 CIT ELMO3 SOS1 | 1.88e-04 | 391 | 242 | 15 | 2.30.29.30 |
| Domain | JmjN | 2.41e-04 | 10 | 242 | 3 | SM00545 | |
| Domain | JmjN | 2.41e-04 | 10 | 242 | 3 | PF02375 | |
| Domain | JMJN | 2.41e-04 | 10 | 242 | 3 | PS51183 | |
| Domain | JmjN | 2.41e-04 | 10 | 242 | 3 | IPR003349 | |
| Domain | PH | PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1 | 2.87e-04 | 278 | 242 | 12 | SM00233 |
| Domain | PH_DOMAIN | PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1 | 2.97e-04 | 279 | 242 | 12 | PS50003 |
| Domain | PH_domain | PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1 | 3.07e-04 | 280 | 242 | 12 | IPR001849 |
| Domain | DNA-dir_DNA_pol_A_palm_dom | 4.97e-04 | 3 | 242 | 2 | IPR001098 | |
| Domain | POLAc | 4.97e-04 | 3 | 242 | 2 | SM00482 | |
| Domain | DNA_pol_A | 4.97e-04 | 3 | 242 | 2 | PF00476 | |
| Domain | DNA_POLYMERASE_A | 4.97e-04 | 3 | 242 | 2 | PS00447 | |
| Domain | PH | 8.37e-04 | 229 | 242 | 10 | PF00169 | |
| Domain | DUF3377 | 9.86e-04 | 4 | 242 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 9.86e-04 | 4 | 242 | 2 | IPR021805 | |
| Domain | Lys_sp_deMease-like_dom | 9.86e-04 | 4 | 242 | 2 | IPR013637 | |
| Domain | PLU-1 | 9.86e-04 | 4 | 242 | 2 | PF08429 | |
| Domain | PROTEIN_KINASE_ATP | SRC OBSCN MAP3K12 ITK PTK6 JAK1 BTK PLK1 FLT1 PAK5 YES1 CIT FRK FYN MAP2K7 | 9.99e-04 | 459 | 242 | 15 | PS00107 |
| Domain | EGF_3 | 1.02e-03 | 235 | 242 | 10 | PS50026 | |
| Pathway | PID_FCER1_PATHWAY | 2.06e-05 | 60 | 199 | 7 | M7 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 2.49e-05 | 13 | 199 | 4 | MM14565 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 6.14e-05 | 16 | 199 | 4 | M537 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 6.95e-05 | 50 | 199 | 6 | M553 | |
| Pubmed | 8.56e-09 | 83 | 248 | 9 | 11114734 | ||
| Pubmed | Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. | 1.25e-08 | 5 | 248 | 4 | 10636929 | |
| Pubmed | 1.25e-08 | 5 | 248 | 4 | 12509223 | ||
| Pubmed | HEXA BRPF3 SRC EPX PIK3C2B MYO18B DNM2 CACNA1F CSF2RA CELSR3 CELF2 LRP2 RIMS1 FYN SOS1 | 1.79e-08 | 329 | 248 | 15 | 17474147 | |
| Pubmed | 3.74e-08 | 6 | 248 | 4 | 20606012 | ||
| Pubmed | 4.09e-08 | 28 | 248 | 6 | 18067320 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 4.46e-08 | 100 | 248 | 9 | 25807483 | |
| Pubmed | Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. | 8.69e-08 | 7 | 248 | 4 | 12526739 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 MYO7A KDM5C OBSCN ALDH1L1 NEB DYSF PIK3C2B PLK1 FLII FLT1 BRD3 ECPAS LCP2 DNAI1 VPS13D ATM | 1.30e-07 | 497 | 248 | 17 | 36774506 |
| Pubmed | 1.48e-07 | 56 | 248 | 7 | 22745667 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | UBR1 EPRS1 IFT140 ACP5 SRC EXT2 PLD3 MAP3K12 MESD GLB1 SBF1 PRMT1 MBD4 PLK1 DNM2 EPS8L2 GEMIN2 RCN2 BRD3 KIAA1191 LCP2 ANKZF1 CRABP1 SNW1 PDE4DIP FYN | 1.63e-07 | 1124 | 248 | 26 | 21900206 |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | ZHX3 IFT140 GALNT3 SRC MECOM BTK OSBPL6 EPS8L2 VPS39 UQCC2 LCP2 ANKZF1 YES1 USP2 FYN | 3.11e-07 | 410 | 248 | 15 | 25814554 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYT1 SRC NAIP OBSCN ADGRV1 PLD3 MAP3K12 PTK6 SEL1L3 COL5A1 FUT10 NEDD4L TMPRSS6 WWP2 ECPAS BABAM2 CREBBP ANKH AR DPP9 SUGP2 NAT10 VPS41 LRP1 CSTF3 RIMS1 TANGO2 PATJ CTDSPL SLC4A5 | 3.35e-07 | 1489 | 248 | 30 | 28611215 |
| Pubmed | SRC ITK PTK6 MMP24 PRMT1 PLK1 MMP15 DNM2 FUT10 NSD1 ADAM30 BRD3 YES1 CREBBP FRK DPP9 LRP1 LRP2 FYN DNAH11 | 3.55e-07 | 730 | 248 | 20 | 34857952 | |
| Pubmed | Localized activation of Src-family protein kinases in the mouse egg. | 3.58e-07 | 3 | 248 | 3 | 17449027 | |
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 24350834 | ||
| Pubmed | Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. | 3.58e-07 | 3 | 248 | 3 | 16400523 | |
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 20176789 | ||
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 29674665 | ||
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 23497302 | ||
| Pubmed | Requirement of SRC-family tyrosine kinases in fat accumulation. | 3.58e-07 | 3 | 248 | 3 | 16262245 | |
| Pubmed | Src family kinases are required for integrin but not PDGFR signal transduction. | 3.58e-07 | 3 | 248 | 3 | 10228160 | |
| Pubmed | Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. | 3.58e-07 | 3 | 248 | 3 | 7958873 | |
| Pubmed | Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. | 3.58e-07 | 3 | 248 | 3 | 20080640 | |
| Pubmed | Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes. | 3.58e-07 | 3 | 248 | 3 | 25800007 | |
| Pubmed | Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. | 3.58e-07 | 3 | 248 | 3 | 10635317 | |
| Pubmed | EG-1 interacts with c-Src and activates its signaling pathway. | 4.22e-07 | 22 | 248 | 5 | 16964398 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXA EPHX1 MAN2A2 GALNT3 EXT2 HMOX1 PLD3 OLFML2A CLPTM1L MESD FAT1 GLB1 SEL1L3 CYB5R3 PRMT1 POFUT2 IGSF3 COL5A1 B3GLCT NEDD4L ARV1 GNPTAB RCN2 CELSR3 LRP1 ATM | 5.74e-07 | 1201 | 248 | 26 | 35696571 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZHX3 MBTD1 MECOM ALDH1L1 AARS2 PLK1 GOT1 FLII IPO7 GEMIN2 BRD3 CREBBP PDE12 RPL4 | 1.23e-06 | 398 | 248 | 14 | 35016035 |
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 7681396 | ||
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 19258394 | ||
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 22577141 | ||
| Pubmed | State and role of SRC family kinases in replication of herpes simplex virus 1. | 1.43e-06 | 4 | 248 | 3 | 16537602 | |
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 14559149 | ||
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 11245687 | ||
| Pubmed | Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. | 1.43e-06 | 4 | 248 | 3 | 7537495 | |
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 16585062 | ||
| Pubmed | Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation. | 1.43e-06 | 4 | 248 | 3 | 25157176 | |
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 7521304 | ||
| Pubmed | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. | 1.43e-06 | 4 | 248 | 3 | 25080486 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 SRC PLD3 F5 XAB2 AARS2 COX5A NOC4L PRMT1 FLII XRN2 IPO7 NEDD4L GEMIN2 LARS1 YES1 CIT SNW1 SUGP2 NAT10 CSTF3 EIF3B FYN | 1.44e-06 | 1024 | 248 | 23 | 24711643 |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 1.51e-06 | 50 | 248 | 6 | 19807924 | |
| Pubmed | IFT140 BRPF3 KDM5C ADGRV1 MESD SBF1 IGSF3 PDPR VPS39 LARS1 ECPAS ANKH CELSR3 DDHD1 CHD5 NAT10 | 1.54e-06 | 529 | 248 | 16 | 14621295 | |
| Pubmed | 1.72e-06 | 13 | 248 | 4 | 16162939 | ||
| Pubmed | 1.98e-06 | 156 | 248 | 9 | 29961565 | ||
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 2.39e-06 | 14 | 248 | 4 | 29568343 | |
| Pubmed | 3.24e-06 | 15 | 248 | 4 | 25036101 | ||
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 3.54e-06 | 5 | 248 | 3 | 12846735 | |
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 17623777 | ||
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 10844001 | ||
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 28822039 | ||
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 3.54e-06 | 5 | 248 | 3 | 18194650 | |
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 18255094 | ||
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 11448999 | ||
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 3.54e-06 | 5 | 248 | 3 | 22971575 | |
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 17394141 | ||
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 3.54e-06 | 5 | 248 | 3 | 25354453 | |
| Pubmed | Isolation of novel heart-specific genes using the BodyMap database. | 3.54e-06 | 5 | 248 | 3 | 11374908 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 HEXA MAN2A2 MYO7A MYO10 OBSCN IPP DYSF FAT1 SBF1 PIK3C2B SPHK1 IGSF3 WDR24 FLII LPAR5 VPS39 NSD1 BABAM2 CIT CELSR3 SUGP2 CHD5 | 5.08e-06 | 1105 | 248 | 23 | 35748872 |
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 5.58e-06 | 17 | 248 | 4 | 23502783 | |
| Pubmed | MON2 IFT140 MBTD1 BRPF3 PSD KDM5C MECOM JAK1 ZNF610 FAT1 HMCN2 IQCM RCN2 ECT2L BRD3 CREBBP SUGP2 CHD5 NAT10 LRP1 LRP2 MAP2K7 SOS1 | 5.97e-06 | 1116 | 248 | 23 | 31753913 | |
| Pubmed | Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells. | 5.98e-06 | 63 | 248 | 6 | 30762338 | |
| Pubmed | HEXA ACP5 SLFN5 HMOX1 CHIT1 PLD3 NEB ANGPTL8 SPG21 FAT1 SRPX2 SPHK1 MBD4 NEDD4L MRGPRF GNPTAB RCN2 ALS2 NARS2 LGALS8 CELF2 PDE4DIP ZNF747 TANGO2 POLQ | 6.97e-06 | 1293 | 248 | 25 | 15342556 | |
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 7.05e-06 | 6 | 248 | 3 | 10861086 | |
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 16982810 | ||
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 12923167 | ||
| Pubmed | The small GTPase Arl8b regulates assembly of the mammalian HOPS complex on lysosomes. | 7.05e-06 | 6 | 248 | 3 | 25908847 | |
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 16723512 | ||
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 9799234 | ||
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 19420001 | ||
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 7.05e-06 | 6 | 248 | 3 | 2404338 | |
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 1381360 | ||
| Pubmed | HEXA EXT2 PLD3 XAB2 JAK1 CLPTM1L MESD FAT1 GLB1 NOC4L POFUT2 DNM2 MPST COL5A1 EPS8L2 IPO7 NEDD4L GEMIN2 LARS1 RCN2 ANKZF1 YES1 BABAM2 FYN RPL4 | 7.35e-06 | 1297 | 248 | 25 | 33545068 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MON2 HEXA ALDH1L1 PLD3 EPX DYSF QSOX1 GLB1 GGTLC3 CLN5 C8A GOT1 DNM2 MPST EPS8L2 NEDD4L WWP2 APOD FRK SNX18 LRP2 PATJ | 9.94e-06 | 1070 | 248 | 22 | 23533145 |
| Pubmed | MON2 EPRS1 ALDH1L1 PHKA1 CLPTM1L GLB1 AARS2 GLDC PARL CYB5R3 PRMT1 POFUT2 MPST NARS2 PDE12 LRP1 MAP2K7 | 1.02e-05 | 686 | 248 | 17 | 28380382 | |
| Pubmed | 1.23e-05 | 7 | 248 | 3 | 9632142 | ||
| Pubmed | Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling. | 1.23e-05 | 7 | 248 | 3 | 11606584 | |
| Pubmed | 1.23e-05 | 7 | 248 | 3 | 10858437 | ||
| Pubmed | 1.23e-05 | 7 | 248 | 3 | 12538589 | ||
| Pubmed | CMS: an adapter molecule involved in cytoskeletal rearrangements. | 1.23e-05 | 7 | 248 | 3 | 10339567 | |
| Pubmed | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. | 1.23e-05 | 7 | 248 | 3 | 10829062 | |
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 1.23e-05 | 7 | 248 | 3 | 16438943 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 1.23e-05 | 7 | 248 | 3 | 12558988 | |
| Pubmed | Interaction of SLP adaptors with the SH2 domain of Tec family kinases. | 1.23e-05 | 7 | 248 | 3 | 10556826 | |
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 1.23e-05 | 7 | 248 | 3 | 12138090 | |
| Pubmed | 1.41e-05 | 73 | 248 | 6 | 24728074 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SRC ALDH1L1 ADGRV1 PLD3 NEB DYSF EHD2 MMP24 FAT1 GLB1 GOT1 DNM2 MPST EPS8L2 APOD FRK VPS13D SNX18 LRP2 PATJ CTDSPL | 1.47e-05 | 1016 | 248 | 21 | 19056867 |
| Pubmed | ZHX3 GALNT3 MYO7A NEB CLPTM1L COX5A IGSF3 DNM2 IPO7 SMARCAL1 ADAM30 BABAM2 CREBBP NARS2 DDHD1 DNAH11 | 1.62e-05 | 638 | 248 | 16 | 31182584 | |
| Pubmed | EPRS1 ACADM AARS2 NOC4L DNM2 XRN2 IPO7 LARS1 RCN2 ECPAS SUGP2 NAT10 CSTF3 EIF3B MAP2K7 RPL4 | 1.62e-05 | 638 | 248 | 16 | 33239621 | |
| Pubmed | 1.67e-05 | 203 | 248 | 9 | 19953087 | ||
| Pubmed | 1.92e-05 | 77 | 248 | 6 | 22973453 | ||
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 15190072 | ||
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 21829547 | ||
| Pubmed | The GTPase dynamin binds to and is activated by a subset of SH3 domains. | 1.95e-05 | 8 | 248 | 3 | 8402898 | |
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 7499252 | ||
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 12526740 | ||
| Pubmed | Receptor association and tyrosine phosphorylation of S6 kinases. | 1.95e-05 | 8 | 248 | 3 | 16640565 | |
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 12640114 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 1.95e-05 | 8 | 248 | 3 | 16921024 | |
| Pubmed | 1.95e-05 | 8 | 248 | 3 | 8810341 | ||
| Cytoband | 2q24-q31 | 8.69e-05 | 3 | 248 | 2 | 2q24-q31 | |
| GeneFamily | SH2 domain containing | 7.28e-06 | 101 | 179 | 8 | 741 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP | MAGEA4 IFT140 BCAT2 EXT2 OLFML2A MMP24 GLDC PLK1 IGSF3 FLII CD1D CTDSPL | 4.60e-07 | 200 | 246 | 12 | M9594 |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN | MORC1 MAN2A2 MYO10 ACP5 ACSS2 PLD3 NEB ANGPTL8 MGAT3 NEDD4L TIMP4 | 3.25e-06 | 200 | 246 | 11 | M5693 |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_5 | 1.26e-05 | 16 | 246 | 4 | M13462 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | HGF RELN HLA-DRB1 ITK MGAT3 CLIC2 VNN2 BTK SEL1L3 ROBO3 MRC1 LCP2 CD1D CSF2RA CELF2 FYN | 1.57e-05 | 485 | 246 | 16 | M8513 |
| Coexpression | GSE17721_CTRL_VS_CPG_24H_BMDC_UP | 2.09e-05 | 200 | 246 | 10 | M3771 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MYO7A ACP5 HMOX1 PLD3 EHD2 SPHK1 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4 | 1.33e-09 | 199 | 247 | 12 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MYO7A ACP5 HMOX1 PLD3 EHD2 SPHK1 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4 | 1.33e-09 | 199 | 247 | 12 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-08 | 164 | 247 | 10 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-08 | 177 | 247 | 10 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 182 | 247 | 10 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 182 | 247 | 10 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 182 | 247 | 10 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-08 | 184 | 247 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.21e-07 | 104 | 247 | 8 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-07 | 195 | 247 | 10 | 1f07502597e9476345b07f9f25aeeb6c1de13013 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-07 | 183 | 247 | 9 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.72e-07 | 185 | 247 | 9 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.72e-07 | 185 | 247 | 9 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.72e-07 | 185 | 247 | 9 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.72e-07 | 185 | 247 | 9 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.72e-07 | 185 | 247 | 9 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.72e-07 | 185 | 247 | 9 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.72e-07 | 185 | 247 | 9 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-06 | 186 | 247 | 9 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 187 | 247 | 9 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-06 | 188 | 247 | 9 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 190 | 247 | 9 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 190 | 247 | 9 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-06 | 190 | 247 | 9 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 191 | 247 | 9 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 191 | 247 | 9 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 191 | 247 | 9 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 192 | 247 | 9 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-06 | 195 | 247 | 9 | 36d4a11bc77a4cc97a22525c78ef8359f4a3ca66 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.50e-06 | 195 | 247 | 9 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-06 | 196 | 247 | 9 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-06 | 196 | 247 | 9 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 196 | 247 | 9 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-06 | 199 | 247 | 9 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.85e-06 | 200 | 247 | 9 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-06 | 200 | 247 | 9 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-06 | 200 | 247 | 9 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-06 | 200 | 247 | 9 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-06 | 200 | 247 | 9 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-06 | 160 | 247 | 8 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-06 | 170 | 247 | 8 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cell_granulo-myelo|blood / Manually curated celltypes from each tissue | 6.48e-06 | 176 | 247 | 8 | d421b6b8e13894dbcf29548c0a6516c3dee8f9b1 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-06 | 178 | 247 | 8 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-06 | 178 | 247 | 8 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.04e-06 | 178 | 247 | 8 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 179 | 247 | 8 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | LA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.42e-06 | 128 | 247 | 7 | 071becbe97598c2b65580b0989eb664d6fd6c85a | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-06 | 180 | 247 | 8 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | HSPCs-Erythroblasts|HSPCs / Lineage and Cell class | 7.95e-06 | 181 | 247 | 8 | 4ded490f190af7ace343acdf317edc7373484d08 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.97e-06 | 184 | 247 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-06 | 184 | 247 | 8 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.97e-06 | 184 | 247 | 8 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.33e-06 | 185 | 247 | 8 | 5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 186 | 247 | 8 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.70e-06 | 186 | 247 | 8 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 186 | 247 | 8 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.01e-05 | 187 | 247 | 8 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 188 | 247 | 8 | e35104ca327c2d9eb6ffed658051f62f855a0a0e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 189 | 247 | 8 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.09e-05 | 189 | 247 | 8 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 189 | 247 | 8 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 189 | 247 | 8 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 189 | 247 | 8 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 189 | 247 | 8 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 189 | 247 | 8 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 190 | 247 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 191 | 247 | 8 | 5c0c44612b4cdbf89c0f1f219416374a7541f610 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 191 | 247 | 8 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.18e-05 | 191 | 247 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 191 | 247 | 8 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 192 | 247 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 192 | 247 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 192 | 247 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.27e-05 | 193 | 247 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | myeloid-macrophage|World / Lineage and Cell class | 1.27e-05 | 193 | 247 | 8 | b13e694123b87ed8ad1786feb996398ddd84e94b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 194 | 247 | 8 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 194 | 247 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 195 | 247 | 8 | e8fb552f9ab77b656c27abc66af523b56cd9f9ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 195 | 247 | 8 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 195 | 247 | 8 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 1.37e-05 | 195 | 247 | 8 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.37e-05 | 195 | 247 | 8 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 195 | 247 | 8 | 9231e929657542b78a6480d44402866511129c7f | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.42e-05 | 196 | 247 | 8 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-05 | 196 | 247 | 8 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 196 | 247 | 8 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 196 | 247 | 8 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-05 | 196 | 247 | 8 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-05 | 196 | 247 | 8 | fa24d7c4b7c65e98b209db302a16c58ceac1a105 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 247 | 8 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 247 | 8 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 247 | 8 | 1bf69db7e830315c8fa85e6e85b0cb94014e9169 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.47e-05 | 197 | 247 | 8 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-05 | 198 | 247 | 8 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.53e-05 | 198 | 247 | 8 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 198 | 247 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-05 | 198 | 247 | 8 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 198 | 247 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| Drug | H088 | 1.45e-06 | 75 | 245 | 8 | CID000004542 | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A | PPP1R15A NEB MAP3K12 MGAT3 HOXC10 SBF1 CLIC2 MMP15 DNM2 COL5A1 ECPAS LRP2 | 1.61e-06 | 197 | 245 | 12 | 5406_DN |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | IL20RA PPP1R15A PLD3 XAB2 EHD2 HOXC10 NALF1 VNN2 C8A MMP15 EPM2A CREBBP | 1.70e-06 | 198 | 245 | 12 | 6799_UP |
| Drug | homocysteine | ALDH1L1 HMOX1 F5 CHRNA7 APOM CHRFAM7A NOS2 PDPR APOC4 APOD KYAT1 TIMP4 TPH2 | 6.78e-06 | 266 | 245 | 13 | CID000000778 |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A | HGF RGS9 HMOX1 PPP1R15A PTGIS CLIC2 TMPRSS6 GNPTAB RDH16 SLC13A1 PDE4DIP | 7.92e-06 | 192 | 245 | 11 | 3807_UP |
| Drug | ponatinib | 8.50e-06 | 68 | 245 | 7 | ctd:C545373 | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | IFT140 MYT1 HMOX1 XAB2 NALF1 CLIC2 ROBO3 MMP15 CATSPER2 ZNF747 ATM | 8.73e-06 | 194 | 245 | 11 | 4763_DN |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.01e-05 | 197 | 245 | 11 | 3820_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | MBTD1 MYO10 HMOX1 HOXC10 RHBDD3 COL5A1 SUGP2 PDE4DIP LRP2 ZNF747 ATM | 1.01e-05 | 197 | 245 | 11 | 1518_DN |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | ZHX3 IFT140 ALDH1L1 DYSF OLFML2A SBF1 COL5A1 EPM2A GNPTAB PDE4DIP ZNF747 | 1.01e-05 | 197 | 245 | 11 | 6091_DN |
| Drug | MIBK | 1.03e-05 | 70 | 245 | 7 | CID000007909 | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | ZHX3 SRC PPP1R15A MAP3K12 POFUT2 EPM2A GNPTAB APOD SUGP2 PDE4DIP ZNF747 | 1.06e-05 | 198 | 245 | 11 | 6073_DN |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | KDM5C SRC HMOX1 XAB2 OLFML2A SBF1 RHBDD3 MMP15 EPM2A ATM CTDSPL | 1.06e-05 | 198 | 245 | 11 | 3259_DN |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; HL60; HT_HG-U133A | EPHX1 KDM5C PPP1R15A SBF1 VNN2 CLN5 RHBDD3 POFUT2 FLII CATSPER2 ZNF747 | 1.11e-05 | 199 | 245 | 11 | 2331_DN |
| Drug | haloperidol; Up 200; 10uM; PC3; HT_HG-U133A | HGF ZHX3 HMOX1 F5 RHBDD3 CWH43 NRG2 BABAM2 LGALS8 PDE4DIP ATM | 1.11e-05 | 199 | 245 | 11 | 4427_UP |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; MCF7; HT_HG-U133A | MYO7A KDM5C SRC ALDH1L1 PTGIS ITK EHD2 CLIC2 ANKZF1 CRABP1 PATJ | 1.11e-05 | 199 | 245 | 11 | 6511_UP |
| Drug | gabapentin | 4.08e-05 | 59 | 245 | 6 | ctd:C040029 | |
| Drug | 2-methylaspartate | 4.17e-05 | 7 | 245 | 3 | CID000002109 | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | CPPED1 SRC HMOX1 MAP3K12 PTK6 HOXC10 SBF1 COL5A1 CATSPER2 PDE4DIP | 4.84e-05 | 193 | 245 | 10 | 950_UP |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A | 5.06e-05 | 194 | 245 | 10 | 5855_UP | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 5.06e-05 | 194 | 245 | 10 | 4178_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.06e-05 | 194 | 245 | 10 | 4132_DN | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | HMOX1 EHD2 SBF1 PIK3C2B VPS39 VPS13D ELMO3 PDE12 CATSPER2 ATM | 5.28e-05 | 195 | 245 | 10 | 5455_DN |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | CPPED1 ITK TBC1D12 RHBDD3 COL5A1 ANKZF1 VPS13D CELSR3 CELF2 FYN | 5.28e-05 | 195 | 245 | 10 | 7140_UP |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | MORC1 MYT1 ALDH1L1 PTGIS CASQ2 APOC4 TEX13A LCP2 PDE4DIP MAP2K7 | 5.51e-05 | 196 | 245 | 10 | 4461_UP |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.75e-05 | 197 | 245 | 10 | 5400_DN | |
| Drug | AC1L1J0H | 5.75e-05 | 197 | 245 | 10 | CID000004813 | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | MYT1 MAP3K12 MMP24 COL5A1 CWH43 NRG2 USP2 CHD5 PDE4DIP MAP2K7 | 5.75e-05 | 197 | 245 | 10 | 3062_UP |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A | IFT140 KDM5C XAB2 OLFML2A PIK3C2B RHBDD3 APOD ANKZF1 ELMO3 PDE4DIP | 5.75e-05 | 197 | 245 | 10 | 5616_DN |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 5.75e-05 | 197 | 245 | 10 | 5843_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | CPPED1 MAP3K12 CLN5 ANKZF1 KYAT1 VPS13D ELMO3 SUGP2 FYN SOS1 | 5.75e-05 | 197 | 245 | 10 | 6222_DN |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 5.75e-05 | 197 | 245 | 10 | 5993_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | MON2 IFT140 GALNT3 ALDH1L1 PPP1R15A NEB PTK6 SBF1 ABCC2 ROBO3 | 5.75e-05 | 197 | 245 | 10 | 2326_DN |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.85e-05 | 159 | 245 | 9 | 1011_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 245 | 10 | 3175_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | HMOX1 OLFML2A SBF1 CRABP1 KYAT1 VPS13D ELMO3 PDE12 ZNF747 ATM | 6.00e-05 | 198 | 245 | 10 | 6790_DN |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A | HOXC10 NALF1 SBF1 RHBDD3 IGSF3 CWH43 GNPTAB BABAM2 VPS13D VPS41 | 6.00e-05 | 198 | 245 | 10 | 5790_DN |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | OLFML2A HOXC10 SBF1 CLIC2 VPS39 APOD VPS13D PDE12 LRP2 ZNF747 | 6.00e-05 | 198 | 245 | 10 | 5405_DN |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | DYSF PTGIS MMP15 EPM2A GNPTAB CRABP1 ELMO3 CELF2 ZNF747 CTDSPL | 6.00e-05 | 198 | 245 | 10 | 5266_DN |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 245 | 10 | 6267_UP | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | KDM5C HMOX1 PTK6 PIK3C2B SPHK1 RHBDD3 FLII CELSR3 PDE4DIP LRP2 | 6.00e-05 | 198 | 245 | 10 | 5470_DN |
| Drug | Dichlorvos | 6.17e-05 | 92 | 245 | 7 | ctd:D004006 | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | ZHX3 IFT140 MAN2A2 PPP1R15A PTK6 HOXC10 APOD AR PDE12 PDE4DIP | 6.26e-05 | 199 | 245 | 10 | 1009_UP |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; MCF7; HT_HG-U133A | XAB2 HOXC10 NALF1 RHBDD3 MMP15 EPM2A BRD3 BABAM2 KYAT1 PDE4DIP | 6.26e-05 | 199 | 245 | 10 | 5002_DN |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.26e-05 | 199 | 245 | 10 | 4990_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | GABRD IFT140 NEB OLFML2A SRPX2 VNN2 NRG2 CHD5 PDE4DIP MAP2K7 | 6.26e-05 | 199 | 245 | 10 | 2787_UP |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.26e-05 | 199 | 245 | 10 | 3531_DN | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | RELN IL20RA PLD3 DYSF MGAT3 RHBDD3 POFUT2 CRABP1 LGALS8 SOS1 | 6.26e-05 | 199 | 245 | 10 | 3569_UP |
| Drug | cypermethrin | EPHX1 HMOX1 NEB KCNJ9 MBD4 NOS2 GOT1 ALS2 AR KYAT1 ATM CDH12 | 6.36e-05 | 284 | 245 | 12 | ctd:C017160 |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | KDM5C HMOX1 PLD3 DYSF SBF1 COL5A1 ANKZF1 KYAT1 CELSR3 ZNF747 | 6.53e-05 | 200 | 245 | 10 | 4789_DN |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A | RELN MAN2A2 MYO7A ALDH1L1 EPX MMP24 MMP15 ECPAS VPS13D CTDSPL | 6.53e-05 | 200 | 245 | 10 | 1474_UP |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | MORC1 HGF VNN2 CREBBP VPS13D SLC13A1 PDE4DIP ZNF747 RIMS1 FYN | 6.53e-05 | 200 | 245 | 10 | 6023_UP |
| Drug | latanoprost acid | 6.70e-05 | 40 | 245 | 5 | CID006441636 | |
| Drug | Ethoxyquin | 6.70e-05 | 40 | 245 | 5 | ctd:D005015 | |
| Drug | AC1L1FO2 | 6.78e-05 | 21 | 245 | 4 | CID000003321 | |
| Drug | UDP-N-acetylglucosamine | HEXA GALNT3 EXT2 CHIT1 MGAT3 GLB1 B3GLCT GNPTAB UGT1A1 SLC4A5 | 7.39e-05 | 203 | 245 | 10 | CID000001167 |
| Drug | Biliton | 7.57e-05 | 41 | 245 | 5 | CID000002974 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | MBTD1 PSD MYT1 RGS9 SMIM15 ISM2 ABCC2 PLK1 NOS2 CACNA1F FLT1 EPS8L2 NEDD4L ALS2 MAGEB16 APOD BABAM2 AR UGT1A1 ESYT3 CD1D ELMO3 CELSR3 TIMP4 PDE4DIP CENPI RIMS1 ATM POLQ SLC4A5 CDH8 RUFY4 | 8.05e-05 | 1441 | 245 | 32 | ctd:C009828 |
| Drug | N-methyl-DL-aspartic acid | GABRD RELN SRC ADGRV1 CHRNA7 FAT1 COX5A CHRFAM7A NOS2 CACNA1B FLII CACNA1F GNPTAB NRG2 APOD CIT LRP1 RIMS1 FYN | 9.48e-05 | 655 | 245 | 19 | CID000004376 |
| Drug | magnesium | MYO7A ACP5 SRC RGS9 ADGRV1 EPX PHKA1 MMP24 GLB1 AARS2 COX5A SPHK1 KCNJ9 POLN PLK1 MMP15 NOS2 PMM1 PDPR CASQ2 YES1 NARS2 KYAT1 DNAI1 TUBD1 FYN CTDSPL RPL4 DNAH11 SOS1 | 9.73e-05 | 1325 | 245 | 30 | CID000000888 |
| Drug | vandetanib | 9.85e-05 | 99 | 245 | 7 | CID003081361 | |
| Drug | K00271 | 9.86e-05 | 9 | 245 | 3 | CID005486761 | |
| Drug | Emodin | 1.12e-04 | 173 | 245 | 9 | ctd:D004642 | |
| Drug | K 81 | 1.15e-04 | 2 | 245 | 2 | CID005744870 | |
| Drug | Pyridoxamine-5'-Phosphate | 1.15e-04 | 2 | 245 | 2 | DB02142 | |
| Drug | NSC221991 | 1.26e-04 | 72 | 245 | 6 | CID000004580 | |
| Drug | Dasatinib | 1.40e-04 | 10 | 245 | 3 | DB01254 | |
| Disease | transverse temporal cortex volume measurement | 8.77e-07 | 10 | 241 | 4 | EFO_0010336 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.41e-06 | 68 | 241 | 7 | DOID:5419 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.21e-06 | 30 | 241 | 5 | DOID:9256 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 1.06e-05 | 6 | 241 | 3 | DOID:2741 (is_implicated_in) | |
| Disease | Autistic Disorder | RELN KDM5C HLA-DRB1 CHRNA7 ROBO3 MBD4 NOS2 NSD1 AR TPH2 RIMS1 | 1.11e-05 | 261 | 241 | 11 | C0004352 |
| Disease | Schizophrenia | GABRD PI4K2B RELN PSD HLA-DRB1 RGS9 HMOX1 CHRNA7 CHRFAM7A CACNA1B CACNA1F VPS39 APOD CSF2RA CELF2 TPH2 LRP1 LRP2 ATM FYN MAP2K7 | 1.34e-05 | 883 | 241 | 21 | C0036341 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.98e-05 | 139 | 241 | 8 | DOID:3908 (is_implicated_in) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 7.62e-05 | 28 | 241 | 4 | DOID:8634 (is_marker_for) | |
| Disease | melanoma | 8.23e-05 | 126 | 241 | 7 | EFO_0000756 | |
| Disease | pulmonary emphysema (is_implicated_in) | 8.46e-05 | 11 | 241 | 3 | DOID:9675 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.30e-04 | 32 | 241 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.75e-04 | 100 | 241 | 6 | DOID:1824 (biomarker_via_orthology) | |
| Disease | brain ischemia (implicated_via_orthology) | 1.86e-04 | 35 | 241 | 4 | DOID:2316 (implicated_via_orthology) | |
| Disease | endothelial growth factor measurement, hepatocyte growth factor measurement | 1.98e-04 | 3 | 241 | 2 | EFO_0006900, EFO_0006903 | |
| Disease | endometrial cancer (is_implicated_in) | 2.08e-04 | 36 | 241 | 4 | DOID:1380 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.13e-04 | 195 | 241 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | Pre-Eclampsia | 2.79e-04 | 16 | 241 | 3 | C0032914 | |
| Disease | Blood Coagulation Disorders | 2.79e-04 | 16 | 241 | 3 | C0005779 | |
| Disease | multiple myeloma | 3.24e-04 | 112 | 241 | 6 | EFO_0001378 | |
| Disease | Liddle syndrome (implicated_via_orthology) | 3.94e-04 | 4 | 241 | 2 | DOID:0050477 (implicated_via_orthology) | |
| Disease | hepatitis (biomarker_via_orthology) | 3.94e-04 | 4 | 241 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | tartrate-resistant acid phosphatase type 5 measurement | 3.94e-04 | 4 | 241 | 2 | EFO_0020763 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 3.94e-04 | 4 | 241 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | melancholic depression (implicated_via_orthology) | 3.94e-04 | 4 | 241 | 2 | DOID:1595 (implicated_via_orthology) | |
| Disease | Hyperbilirubinemia | 3.94e-04 | 4 | 241 | 2 | C0020433 | |
| Disease | Kartagener syndrome (is_implicated_in) | 3.94e-04 | 4 | 241 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 4.02e-04 | 163 | 241 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 4.17e-04 | 43 | 241 | 4 | DOID:9261 (is_marker_for) | |
| Disease | Disproportionate short stature | 4.27e-04 | 77 | 241 | 5 | C0878659 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.97e-04 | 45 | 241 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 5.36e-04 | 171 | 241 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | Nonsyndromic Deafness | 5.39e-04 | 81 | 241 | 5 | C3711374 | |
| Disease | Malignant neoplasm of breast | MAGEA4 ACADM SRC OBSCN MECOM HMOX1 DYSF CLPTM1L BTK NOS2 CNGA2 FLT1 VPS39 TMPRSS6 SMARCAL1 APOC4 AR CHD5 ATM MAP2K7 | 5.64e-04 | 1074 | 241 | 20 | C0006142 |
| Disease | Malignant neoplasm of prostate | EPHX1 GALNT3 HMOX1 JAK1 CLPTM1L COL5A1 CREBBP AR CELF2 TIMP4 LRP2 ATM PATJ CDH12 | 5.92e-04 | 616 | 241 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | EPHX1 GALNT3 HMOX1 JAK1 CLPTM1L COL5A1 CREBBP AR CELF2 TIMP4 LRP2 ATM PATJ CDH12 | 5.92e-04 | 616 | 241 | 14 | C0033578 |
| Disease | sciatic neuropathy (is_implicated_in) | 6.54e-04 | 5 | 241 | 2 | DOID:11446 (is_implicated_in) | |
| Disease | platelet-activating factor measurement | 6.54e-04 | 5 | 241 | 2 | EFO_0801075 | |
| Disease | renal hypertension (implicated_via_orthology) | 6.54e-04 | 5 | 241 | 2 | DOID:1073 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 6.54e-04 | 5 | 241 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | atopy | 6.54e-04 | 5 | 241 | 2 | EFO_0002686 | |
| Disease | Liver Cirrhosis, Experimental | HGF ACP5 ALDH1L1 HMOX1 DYSF FAT1 CLIC2 ABCC2 MMP15 NOS2 GOT1 COL5A1 RCN2 LCP2 CELF2 FYN | 6.81e-04 | 774 | 241 | 16 | C0023893 |
| Disease | Hodgkin Disease | 7.39e-04 | 22 | 241 | 3 | C0019829 | |
| Disease | Fibrosis | 7.44e-04 | 50 | 241 | 4 | C0016059 | |
| Disease | Cirrhosis | 7.44e-04 | 50 | 241 | 4 | C1623038 | |
| Disease | sitting height ratio | 8.03e-04 | 51 | 241 | 4 | EFO_0007118 | |
| Disease | serum alanine aminotransferase measurement | PSD HLA-DRB1 PKD1L1 ALDH1L1 ITK MMP24 ABCC2 MMP15 FLT1 NEDD4L WWP2 BRD3 FRK SLC13A1 CELF2 PATJ MAP2K7 | 8.56e-04 | 869 | 241 | 17 | EFO_0004735 |
| Disease | cognitive disorder (implicated_via_orthology) | 9.75e-04 | 6 | 241 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | leiomyosarcoma (is_marker_for) | 9.75e-04 | 6 | 241 | 2 | DOID:1967 (is_marker_for) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 9.75e-04 | 6 | 241 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | leukemia | 1.07e-03 | 55 | 241 | 4 | C0023418 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.08e-03 | 25 | 241 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Colitis | 1.08e-03 | 25 | 241 | 3 | C0009319 | |
| Disease | bilirubin measurement | UBR1 ZHX3 HLA-DRB1 MYT1 EPX CYB5R3 ABCC2 TMPRSS6 APOC4 UGT1A1 DNAH11 | 1.10e-03 | 442 | 241 | 11 | EFO_0004570 |
| Disease | Alzheimer's disease (is_marker_for) | 1.31e-03 | 257 | 241 | 8 | DOID:10652 (is_marker_for) | |
| Disease | aspartate aminotransferase measurement | MYO7A HLA-DRB1 OBSCN IPP HMCN2 GLB1 OSBPL6 ABCC2 MMP15 GOT1 MRC1 NEDD4L NSD1 BRD3 FRK CELF2 SOS1 | 1.31e-03 | 904 | 241 | 17 | EFO_0004736 |
| Disease | hexanoylglycine measurement | 1.36e-03 | 7 | 241 | 2 | EFO_0800233 | |
| Disease | toxic shock syndrome (implicated_via_orthology) | 1.36e-03 | 7 | 241 | 2 | DOID:14115 (implicated_via_orthology) | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.36e-03 | 7 | 241 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 1.36e-03 | 7 | 241 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 1.50e-03 | 150 | 241 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 1.52e-03 | 28 | 241 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | neuroblastoma, cutaneous melanoma | 1.52e-03 | 28 | 241 | 3 | EFO_0000389, EFO_0000621 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.59e-03 | 206 | 241 | 7 | C0152013 | |
| Disease | Lung Neoplasms | 1.59e-03 | 265 | 241 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.63e-03 | 266 | 241 | 8 | C0242379 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.68e-03 | 29 | 241 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.68e-03 | 29 | 241 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.68e-03 | 29 | 241 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 1.68e-03 | 29 | 241 | 3 | C0014518 | |
| Disease | Alcoholic Intoxication, Chronic | 1.70e-03 | 268 | 241 | 8 | C0001973 | |
| Disease | Nemaline myopathy | 1.80e-03 | 8 | 241 | 2 | cv:C0206157 | |
| Disease | Lymphoid leukemia | 1.80e-03 | 8 | 241 | 2 | C0023448 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.86e-03 | 30 | 241 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | Stevens-Johnson Syndrome | 1.86e-03 | 30 | 241 | 3 | C0038325 | |
| Disease | Disorder of eye | 1.87e-03 | 212 | 241 | 7 | C0015397 | |
| Disease | carcinoma (implicated_via_orthology) | 1.88e-03 | 64 | 241 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 2.10e-03 | 66 | 241 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Seizures | 2.18e-03 | 218 | 241 | 7 | C0036572 | |
| Disease | Grand Mal Status Epilepticus | 2.22e-03 | 67 | 241 | 4 | C0311335 | |
| Disease | Petit mal status | 2.22e-03 | 67 | 241 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.22e-03 | 67 | 241 | 4 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 2.22e-03 | 67 | 241 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.22e-03 | 67 | 241 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.22e-03 | 67 | 241 | 4 | C0751523 | |
| Disease | Lymphoma, Non-Hodgkin | 2.24e-03 | 32 | 241 | 3 | C0024305 | |
| Disease | Squamous cell carcinoma of lung | 2.24e-03 | 32 | 241 | 3 | C0149782 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.30e-03 | 9 | 241 | 2 | C3502809 | |
| Disease | Status Epilepticus | 2.35e-03 | 68 | 241 | 4 | C0038220 | |
| Disease | squamous cell lung carcinoma | 2.43e-03 | 165 | 241 | 6 | EFO_0000708 | |
| Disease | Chronic Obstructive Airway Disease | 2.45e-03 | 33 | 241 | 3 | C0024117 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 2.45e-03 | 33 | 241 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Chronic Airflow Obstruction | 2.45e-03 | 33 | 241 | 3 | C1527303 | |
| Disease | anorexia nervosa | 2.61e-03 | 70 | 241 | 4 | MONDO_0005351 | |
| Disease | macrovascular complications of diabetes | 2.86e-03 | 10 | 241 | 2 | EFO_0010977 | |
| Disease | Peripheral T-Cell Lymphoma | 2.86e-03 | 10 | 241 | 2 | C0079774 | |
| Disease | CXCL5 measurement | 2.86e-03 | 10 | 241 | 2 | EFO_0009422 | |
| Disease | Leukemia, Myelocytic, Acute | 3.07e-03 | 173 | 241 | 6 | C0023467 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.19e-03 | 74 | 241 | 4 | DOID:3748 (is_marker_for) | |
| Disease | lung cancer (is_implicated_in) | 3.19e-03 | 74 | 241 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | intraocular pressure measurement | CFAP95 RELN HLA-DRB1 MECOM COL5A1 BRD3 BABAM2 ANKH ELMO3 TANGO2 FYN | 3.30e-03 | 509 | 241 | 11 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PELYEIFLSRAKERW | 506 | O60347 | |
| AYEELRLDSFKDWPR | 276 | Q13075 | |
| WYEIEKIPTTFENGR | 46 | P05090 | |
| EDLIKGFSQWYELTP | 866 | A0FGR9 | |
| AWPFYKPVDAEALEL | 331 | Q15059 | |
| DLLLDERSPYWACKG | 221 | Q8NCV1 | |
| QWYFIAGAAPTKEEL | 46 | O95445 | |
| WSEKELKELFEPYGA | 51 | O95319 | |
| PFKDLGNLRYWLEEA | 286 | P55884 | |
| LRRYDPSKEWFLGKA | 146 | Q6Y288 | |
| WPRDSLFRYFELLEK | 491 | Q96P56 | |
| IPEREFFVKWAGLSY | 506 | Q8TDI0 | |
| WGRSLKYNPVVIDFE | 446 | P07357 | |
| GYGSWEIDPKDLTFL | 391 | Q06187 | |
| RKEAEYTLGFWKTFP | 886 | Q96Q42 | |
| DPRLKDATYDGRWLS | 1041 | Q96Q42 | |
| SRGYDFPAVLRWFAE | 166 | Q9NZN4 | |
| KPQWKAYDDVFRGRT | 6086 | Q8WXG9 | |
| EFLEIGGSKPFRSYW | 66 | Q6T311 | |
| LTSAKELPYFEGDFW | 1531 | Q92793 | |
| ANSKVPWEDLRYLFG | 4126 | Q96DT5 | |
| PESPKLEDFYRFSWE | 711 | Q9ULD4 | |
| LRPEVRDFWEKLGSY | 366 | Q008S8 | |
| QLRSAWLGPAYREFE | 136 | Q6UXH0 | |
| EYRDQVGTLLPLWKF | 311 | Q9UI46 | |
| GKANWYFLLARSDPD | 196 | P11310 | |
| EEPREFWGDIAKEFY | 56 | Q9NR19 | |
| YDDHLRDLGPLTKAW | 86 | P55056 | |
| DDEDKLTWKDRFPGY | 521 | Q9NQ90 | |
| DWARDIGIPFSYTFE | 296 | Q8IVL8 | |
| LDEFIRVWAEYDPAA | 1726 | Q00975 | |
| DDLKWSRLPLAFAYR | 1821 | O14578 | |
| IKPYGLDWAELSRDL | 1266 | O14525 | |
| WDLVGIPGKRSERFY | 196 | P36544 | |
| TVLYARDKWLAPDGL | 176 | Q99873 | |
| KDYGLWQLFRTLELP | 416 | Q7Z5Q5 | |
| VSLEEFLGDYRWDPT | 206 | Q14257 | |
| ARFKLWYTLDRAPEA | 231 | P00387 | |
| YEVGDLIWAKFKRRP | 321 | Q96L73 | |
| DVKAWRPALYLAALD | 86 | O00391 | |
| LEGDGPKTYWTRELA | 101 | P29762 | |
| EEIYKLFLAPGARRW | 351 | O75916 | |
| KEPDKAFYDWRGFVL | 186 | A0A1B0GVH7 | |
| TVKDDRDSPVFWYAP | 1036 | P23458 | |
| ELRSFEVYDPLSKRW | 451 | Q9Y573 | |
| EGSPDLWKVTYKRDL | 256 | A4D126 | |
| DAHLYWSIPSRLDEK | 346 | Q92806 | |
| NLKDPSYGWEILDEF | 116 | Q03112 | |
| GALEDFPARWSFRAY | 226 | Q86VD1 | |
| WHRDREAFPKGYDIE | 51 | Q5VTT2 | |
| FLRKYSFDGLDLDWE | 126 | Q13231 | |
| LDESGSYWVSDKRLP | 806 | P35228 | |
| EWGPSLDDYDRRPKS | 256 | Q9P286 | |
| EGWPALLYKAIDAYA | 1086 | O60840 | |
| EFKRIWSEYDPGAKG | 1461 | O60840 | |
| PAWEVRYKIVSGDSE | 66 | Q14517 | |
| FWKGLPARIDAAYER | 421 | Q9Y5R2 | |
| IDTALRWEPVGKTYF | 476 | Q9Y5R2 | |
| ARDLTKIFEAYWFLG | 241 | Q8IV08 | |
| FWPAIDDGLRRATYE | 341 | Q8IV08 | |
| AEPGRVDTFWYKFLK | 76 | O95278 | |
| VDTFWYKFLKREPGG | 81 | O95278 | |
| YKFLKREPGGELSWE | 86 | O95278 | |
| WDQGLEKPRLDYSEF | 476 | Q13045 | |
| VYAWVGRASDPDEAK | 1101 | Q13045 | |
| KAFRESVRPGWEYIG | 41 | Q9HCP6 | |
| EFLWGPRALAETSYV | 271 | P43358 | |
| SDPRSFPLWYEEALK | 321 | P43363 | |
| ARYEFLWGPRAKAET | 271 | A2A368 | |
| FESFSDELWKGRLLP | 176 | Q9H1C0 | |
| KLPFKWFDYLRETGS | 461 | Q05BQ5 | |
| WFDYLRETGSIAAPV | 466 | Q05BQ5 | |
| DFTPELGRWLYALLA | 206 | O14893 | |
| DGKELTISPAYLLWD | 291 | Q3T906 | |
| GVLFLKLYDGWTEPF | 326 | Q09327 | |
| LLPADRKWGFITVGY | 156 | Q68DU8 | |
| WGREEITYDTPFKRE | 86 | O00214 | |
| IAPIYWALARESGEA | 4451 | Q8NDA2 | |
| GLLPASYDQKDAWVR | 31 | P46020 | |
| GLAIDFPESKLYWIS | 1746 | Q07954 | |
| LRDGSYAWEIKDFLV | 161 | Q14696 | |
| FWRGLPGDISAAYER | 411 | P51511 | |
| WAEFQDPLGYIAKIR | 21 | Q9BY66 | |
| DPDYLAAVDKWLGVL | 151 | P16278 | |
| YLLGAFESLGKAWPR | 1691 | Q5VYK3 | |
| LAPGDWVFKDSVSYD | 311 | Q6H9L7 | |
| DYPSRWTAIVDKIGF | 121 | O95373 | |
| KPDYDIRADVWSLGI | 296 | O14733 | |
| GYPSENVWELDLKRF | 406 | Q8NCN5 | |
| EFGDPASSLFRWYKE | 186 | Q6L8Q7 | |
| ALARWLPAEYEDGLS | 166 | P11678 | |
| RLPAGVSWLEFIYSK | 676 | A0A1B0GTH6 | |
| FPSSGRFWKLYIEAE | 61 | Q12996 | |
| PSYRWFKDGKELNRS | 266 | O14511 | |
| LAATSEVGDLPWKFY | 1771 | Q9HD67 | |
| EAINFATPRWIDYGK | 291 | Q6B0I6 | |
| LPRASAIKALDVYFW | 301 | O14764 | |
| GYKRPLTLEDVWEVD | 216 | Q92887 | |
| DRLSFKWGESDPLPY | 436 | Q2TBA0 | |
| WADYGQRPKIERSFL | 2206 | P98164 | |
| AVDYDWDPKDIGLSV | 4086 | P98164 | |
| LRTDDWAVLPLAGDY | 856 | Q2VPB7 | |
| RIKLENPLDYGSAWA | 386 | P10275 | |
| FPSRDLKDYEAWLGI | 536 | P14210 | |
| YLLQPLGDFSRAWDV | 1131 | Q7Z3U7 | |
| DKWSLFGPRSLQKYD | 221 | Q96A73 | |
| IWTESAFRKLDELYG | 251 | P36578 | |
| WKASFLRAGVYPEKD | 616 | P50570 | |
| VSNDTYWELRKDPGF | 911 | Q9BZF3 | |
| YWELRKDPGFSKVDS | 916 | Q9BZF3 | |
| WDLVGIPGKRSERFY | 106 | Q494W8 | |
| YESGPDEVRAWLEAK | 626 | Q9H6S3 | |
| YAPGDAVEKWLNDLL | 471 | Q9H0A0 | |
| SKWAESGRFYPFLET | 121 | Q9UHF4 | |
| FDRFEGKLSPLWYKI | 1451 | P78509 | |
| WFGYDVKRAVEEPRL | 146 | B5MD39 | |
| KVWDFYTEETLAEGP | 1591 | O95248 | |
| PKYVGLWDFKSRTDE | 11 | Q13882 | |
| SLISWDEPGVDFYSK | 56 | O00750 | |
| VSEKGDLDYYWLDPA | 556 | Q86UR5 | |
| WYLDFLAPAKATLGE | 351 | P04062 | |
| YLDRRLKLSPEWGAA | 5661 | Q5VST9 | |
| AEYWLRKFEADPLPE | 266 | Q8TCG2 | |
| ERPTFETLRWKLEDY | 476 | P42685 | |
| DPAIWFEKRLAYTRS | 2841 | Q13315 | |
| WTDFNKIRVGYPELA | 256 | Q9UKF2 | |
| KEWYRLTEEESAPIG | 1091 | O75054 | |
| LGFAIYWFISRDKEE | 11 | P07099 | |
| YWFISRDKEETLPLE | 16 | P07099 | |
| YRLWEEGIVASLDDP | 91 | A8MY62 | |
| KDLAKTNELDFWYPG | 41 | P15088 | |
| PYAGETLKWDIIFNA | 61 | Q9NXR7 | |
| LYKDVRDLLAGPSWA | 271 | Q9H8Y5 | |
| TAPDDLIRYAKEWDF | 126 | Q9H2C2 | |
| GDILPNADETWYLRA | 251 | P15813 | |
| LAKYADPVADLLDRW | 171 | O15194 | |
| AFAGRYAFRIWKPLE | 51 | Q9Y5T4 | |
| FPKVEYIARAGWTRD | 346 | Q86TI2 | |
| ECFYGWLEPLLARIA | 281 | Q14435 | |
| DDYITEKFWRPLKLG | 286 | Q6P4F1 | |
| KWTAPEAALYGRFTI | 431 | P06241 | |
| VPDYERDKLLLANWG | 61 | O75417 | |
| FRAVTELGRPDAEYW | 76 | P01911 | |
| YWDAEKRGLDLQGFL | 161 | P17174 | |
| GWLTEIRAVYPAFDK | 291 | Q9HCJ1 | |
| DYPLFRGINLSDGKW | 151 | P20908 | |
| ESEWKGPFYFILGAD | 26 | Q9BRF8 | |
| PSKREFYLWTDGLSA | 646 | Q96BJ8 | |
| EYRRFLDWGAPNAKV | 151 | P07316 | |
| WELLTGEIPYKDVDS | 301 | Q12852 | |
| WRDVSELLKPLGLYD | 496 | O95243 | |
| LDSWGDPKAAYRLEQ | 76 | Q9NYD6 | |
| VPLGDDFRYDKPQEW | 421 | P49641 | |
| KAALEQDLAFWYGPR | 86 | P09601 | |
| IDPDDFPLLVAYWEK | 306 | O14958 | |
| DYLTDWGPRFKVLAD | 766 | P55289 | |
| TELGPEEVRWFYKED | 161 | Q8NEL9 | |
| LSDWGPRFKRLGELY | 776 | P55286 | |
| EAFLYKSLPLWDGLC | 436 | Q92674 | |
| KDVDGNDLLSYWPAL | 2941 | Q9NYQ7 | |
| KDWVPDAAGTSLYVR | 156 | O15382 | |
| EFDARWVTYFNKPDI | 51 | P20674 | |
| VTYDDKAEAGPFSWI | 216 | P60507 | |
| GEIVAFDYSPLITWK | 411 | Q9BZW2 | |
| YLRKWLLLSDPDDFS | 316 | O75923 | |
| RFWDIERGENYILSP | 301 | Q96RY7 | |
| KSKWEGNYLFPRELF | 136 | Q9BVI4 | |
| KETIPLEFEWYFGED | 531 | Q8TDX9 | |
| RDFDIPAEFSGVWRY | 201 | O15247 | |
| IIWEEFTPEEGKGYR | 376 | P15509 | |
| SAFLKAWVYRPGEDT | 426 | O75807 | |
| DESGLWVIYPAVDDR | 526 | Q68BL7 | |
| LRYGKWVIDPSELTF | 351 | Q08881 | |
| YFDGIKADWLDSIRP | 131 | Q9H300 | |
| GLRPEKYFWTGLSDI | 556 | P22897 | |
| WKDFYIVEPLAFEGT | 431 | P06865 | |
| KEVSAAIWPFRFGYD | 426 | Q9H720 | |
| DEEETKYEIFPWALG | 136 | Q5MJ70 | |
| WTAPEAALYGRFTIK | 431 | P12931 | |
| YERGISLFKWPNVSD | 541 | Q9HCS7 | |
| VRADLRDNYSPGWKF | 1341 | P07814 | |
| LLDASWYLPKLGRDA | 31 | P25325 | |
| WYLPKLGRDARREFE | 36 | P25325 | |
| WYAKGALETEDPALI | 716 | Q68CR1 | |
| ARAKWEFFYGSLDPP | 236 | A5PKW4 | |
| SQIKASEFLGYWEPR | 1921 | P12259 | |
| RFEPTWEELELYKDG | 351 | Q9Y2G5 | |
| YFLAGRDKSQRLWEP | 291 | Q96AM1 | |
| IWDRSSPEVKEAYGE | 226 | O75452 | |
| SIPWLGYALDFGKDA | 36 | Q16647 | |
| PEWGADLRTEHEKYL | 341 | Q96I59 | |
| EFEFWYPVDLRVSGK | 661 | Q9P2J5 | |
| RDRGIFGIESWPDYE | 261 | Q53T94 | |
| DGIDYNPWVEFVKLA | 11 | Q16773 | |
| YLVAKGTADDYLWPL | 831 | Q9NZC9 | |
| LGPRKDYWDFLCTAL | 61 | Q6ZNE9 | |
| VVEWAAKDPYGFLTT | 11 | Q7Z3B0 | |
| DDDSKIWSLYDAGPR | 26 | Q9NZD8 | |
| VFPEGWDKRYCLDSL | 191 | Q92871 | |
| LPYEFFSEENAPKWR | 6 | Q07889 | |
| GIPEERLWISYFDGD | 161 | Q5JTZ9 | |
| RLWISYFDGDPKAGL | 166 | Q5JTZ9 | |
| AEKDGVPVFKYSRWR | 46 | O75891 | |
| RLQAPVWEFKYGDLL | 96 | O75503 | |
| WLYPVDKRRVNEFGE | 511 | Q96KA5 | |
| DYGKRSLPGVNDFWL | 116 | O75596 | |
| KKFELFVLDPAGDWY | 126 | Q16280 | |
| WSKFYRSDPRIALGK | 61 | Q5SQS8 | |
| EEWKSLDPGQRALYR | 36 | Q8N9Z0 | |
| LAYAAGAFRWLEPSE | 176 | Q9Y3P4 | |
| DPDEWRLEKYVGALE | 26 | Q9NZ43 | |
| IVTPEDALYGWKFTR | 76 | O95498 | |
| DALYGWKFTRETVFP | 81 | O95498 | |
| ADVEGFKDPALYTSW | 356 | Q9UJT1 | |
| VAPLEWLRYFDEKEL | 731 | O00308 | |
| PAFKDAVPEYSLWFE | 1676 | Q8NB66 | |
| ARVYWDPPLVKDSAD | 201 | O60687 | |
| ELKSRWENLLGPDYE | 526 | Q8NI35 | |
| EQPSLVWFDRGKFYL | 526 | Q9BQI5 | |
| FDWLYARLAEKFPVI | 316 | Q96RF0 | |
| WRKEDGELPTGRYEI | 291 | Q96MS0 | |
| EFWDTAPAFEGRKEI | 56 | Q8WUN7 | |
| WRKPGAVSFADVAVY | 31 | Q9BV97 | |
| KYAWQGVALLPFVDE | 641 | Q9H0D6 | |
| ERTLLKEDPAYWFLS | 606 | Q8IX01 | |
| DSYILPFSEVLDWKR | 346 | Q93063 | |
| ASVWLFRSDFVKDYP | 251 | P22309 | |
| WYLFGEDPDICLEKL | 76 | Q8IWV7 | |
| WPVDETKRGRDLGAY | 16 | Q9BRT2 | |
| EDVFSDRSLRKVPWY | 91 | P13686 | |
| SWYRGHLPLRKEFVD | 206 | Q99727 | |
| DIKRKLPWFPSDFYD | 501 | Q9BY07 | |
| YRKGWIPRLLEDFGD | 46 | Q13573 | |
| SDYEGFATLIREWPG | 471 | P49754 | |
| KYWARRGFSLDSAVP | 11 | Q8IWU9 | |
| SDPFSWKLPSLDYER | 2421 | Q8IUG5 | |
| GPEFYLENISLSWEK | 31 | Q9BXU3 | |
| YLLSWKESRGNIEPD | 426 | Q8NA56 | |
| DIPFYFSREEWGTLD | 206 | O14771 | |
| FTRDDPYSILEELWK | 106 | Q5JVG2 | |
| WGFIADVDLESEKYR | 171 | Q9NYA1 | |
| WFVDTAERYALAGRP | 411 | Q96S15 | |
| AERLWEYGFLRTPEQ | 446 | Q8IWY8 | |
| DPFWDLSLPIAKRGY | 436 | O75604 | |
| ERLPYDASKWEFARE | 811 | P17948 | |
| PEVVRWFGDSRYALK | 806 | Q9H4I2 | |
| DSLGYAFSKPDLITW | 46 | Q6IV72 | |
| TARDGPGVLWIFLDY | 671 | Q08AF3 | |
| TVPSLDYGLALWFDA | 371 | Q8IU80 | |
| RDEFYSRPSKLADFW | 26 | Q6ICL3 | |
| SYSVWVLRDFPEDGL | 556 | Q96JC1 | |
| IKWTAPEAALYGRFT | 436 | P07947 | |
| EGDELARLPYLRTWF | 501 | P53350 | |
| LKAGPFWRLGVYIDF | 271 | Q309B1 | |
| RAEGSLKIFISAPYW | 3271 | Q5THJ4 | |
| KFWPTIARIDDIYGD | 981 | P23378 | |
| WAEFRDPLGYIAKIR | 21 | P41229 | |
| EVLGWDPDSLADYFK | 11 | Q13094 | |
| YDDGLKIWLAAPREN | 11 | B1AL88 | |
| EDVVSYARFKWPLLF | 1456 | Q13402 | |
| LAEELRSASWPGKYD | 1461 | Q5VU43 | |
| DEWDRPLDYTKPSRL | 726 | Q01538 | |
| WEEALKKGYDLPVDA | 2276 | P20929 | |
| ARLWIEFESEKGLDY | 646 | Q96PU5 |